Blog - Latest News
You are here: Home1 / Dr. Shore Conducts the Poster Presentation at the SUO 2015 Conference in Washington, DC “Significant Reduction in Therapeutic Burden from Use of CCP Test in Treatment Decisions among Newly Diagnosed Prostate Cancer Patients in a Large Prospective Registry” Please join us Wednesday, 12/2 • 4:30pm2 / 12.1-Prolaris
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
- Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
- START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
- Final Version: Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
- The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
Our Affiliates
